AAAAAA

   
Results: 1-9 |
Results: 9
Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour
Authors: Moutquin, JM Cabrol, D Fisk, NM MacLennan, AH Marsal, K Rabinovici, J
Citation: Jm. Moutquin et al., Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour, BR J OBST G, 108(2), 2001, pp. 133-142
Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol
Authors: Cabrol, D Gillet, JY Madelenat, P Lansac, J Paniel, B Dellenbach, P Lemoine, JP Bronstein, R Leng, JJ Laurent, MC Mares, P Hedon, B Magnin, G Treisser, A Schumacher, JC Grosieux, P Jacquetin, P Bruhat, M Segard, L Puech, F Engelmann, P Schweitzer, M Boog, G Boubli, L Duquidt, N Desroches, A Blot, P Milliez, J Tabaste, JL MacLennan, AH Crowther, C Dickinson, JE Peat, BB King, J Fulcher, IR Permezel, JM
Citation: D. Cabrol et al., Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol, EUR J OB GY, 98(2), 2001, pp. 177-185
A guest editorial from abroad: Medicolegal opinion - Time for peer review
Authors: MacLennan, AH
Citation: Ah. Maclennan, A guest editorial from abroad: Medicolegal opinion - Time for peer review, OB GYN SURV, 56(3), 2001, pp. 121-123
How long does it take to deliver a baby by emergency Caesarean section?
Authors: Spencer, MK MacLennan, AH
Citation: Mk. Spencer et Ah. Maclennan, How long does it take to deliver a baby by emergency Caesarean section?, AUST NZ J O, 41(1), 2001, pp. 7-11
The prevalence of pelvic floor disorders and their relationship to gender,age, parity and mode of delivery
Authors: MacLennan, AH Taylor, AW Wilson, DH Wilson, D
Citation: Ah. Maclennan et al., The prevalence of pelvic floor disorders and their relationship to gender,age, parity and mode of delivery, BR J OBST G, 107(12), 2000, pp. 1460-1470
Haematopoietic indicators of fetal metabolic acidosis
Authors: Spencer, MK Khong, TY Matthews, BL MacLennan, AH
Citation: Mk. Spencer et al., Haematopoietic indicators of fetal metabolic acidosis, AUST NZ J O, 40(3), 2000, pp. 286-289
Hormone therapy use in Australian-born women: a longitudinal study
Authors: Guthrie, JR Garamszegi, CV Dudley, EC Dennerstein, L Green, A MacLennan, AH Burger, HG
Citation: Jr. Guthrie et al., Hormone therapy use in Australian-born women: a longitudinal study, MED J AUST, 171(7), 1999, pp. 358-361
Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997 - In reply
Authors: MacLennan, AH Wilson, DH Taylor, AW
Citation: Ah. Maclennan et al., Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997 - In reply, MED J AUST, 171(5), 1999, pp. 275-275
Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997
Authors: MacLennan, AH Wilson, DH Taylor, AW
Citation: Ah. Maclennan et al., Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997, MED J AUST, 170(11), 1999, pp. 524-527
Risultati: 1-9 |